Apellis Pharmaceuticals Competitors and Similar CompaniesClear all

Apellis Pharmaceuticals's competitors and similar companies include Reata Pharmaceuticals and Cipla.

	Apellis Pharmaceuticals Apellis Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds.	Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2009	Founding Date 2002	Founding Date 1935
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Waltham, US HQ Kew East, AU München, DE Zug, CH San Francisco, US Watertown, US	Locations Plano, US HQ Irving, US Plano, US	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 7028% decrease	Employees 3217% decrease	Employees 27,764
Valuation ($)	Valuation ($) 3.3 b	Valuation ($) 6.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $1b (FY, 2025)	Revenue (est.) $2.2m (FY, 2022)	Revenue (est.) ₹277.1b (FY, 2026)
Net income	Net income $22.4m (FY, 2025)	Net income ($311.9m) (FY, 2022)	Net income ₹38.7b (FY, 2026)
Funding
Total funding raised	Total funding raised $ 88m	Total funding raised $ 468.9m	Total funding raised N/A